Free Trial

Sally Beauty (SBH) Financials

Sally Beauty logo
$18.64 -0.33 (-1.71%)
As of 11:47 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Annual Income Statements for Sally Beauty

Annual Income Statements for Sally Beauty

This table shows Sally Beauty's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 9/30/2016 9/30/2017 9/30/2018 9/30/2019 9/30/2020 9/30/2021 9/30/2022 9/30/2023 9/30/2024 9/30/2025 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders
223 215 258 272 113 240 184 185 153 196 200
Consolidated Net Income / (Loss)
223 215 258 272 113 240 184 185 153 196 200
Net Income / (Loss) Continuing Operations
223 215 258 272 113 240 184 185 153 196 200
Total Pre-Tax Income
354 346 328 362 160 325 244 252 206 263 270
Total Operating Income
498 479 427 458 259 418 338 325 283 328 326
Total Gross Profit
1,964 1,965 1,944 1,911 1,716 1,953 1,919 1,898 1,890 1,911 1,944
Total Revenue
3,953 3,938 3,933 3,876 3,514 3,875 3,816 3,728 3,717 3,701 3,735
Operating Revenue
3,953 3,938 3,933 3,876 3,514 3,875 3,816 3,728 3,717 3,701 3,735
Total Cost of Revenue
1,989 1,973 1,988 1,966 1,799 1,922 1,896 1,830 1,827 1,791 1,791
Operating Cost of Revenue
1,989 1,973 1,988 1,966 1,799 1,922 1,896 1,830 1,827 1,791 1,791
Total Operating Expenses
1,466 1,486 1,518 1,452 1,457 1,535 1,582 1,573 1,608 1,583 1,617
Selling, General & Admin Expense
1,466 1,464 1,484 1,453 1,443 1,530 1,554 1,556 1,608 1,583 1,617
Total Other Income / (Expense), net
-144 -133 -98 -96 -99 -94 -94 -73 -76 -64 -56
Interest & Investment Income
- - - - - - - - -76 -64 -56
Income Tax Expense
131 131 70 91 47 85 61 67 53 68 70
Basic Earnings per Share
$1.51 $1.56 $2.09 $2.27 $0.99 $2.13 $1.69 $1.72 $1.48 $1.95 $2.09
Weighted Average Basic Shares Outstanding
147.18M 137.53M 123.19M 119.64M 113.88M 112.65M 108.67M 107.33M 103.94M 100.66M 95.62M
Diluted Earnings per Share
$1.50 $1.56 $2.08 $2.26 $0.99 $2.10 $1.66 $1.69 $1.43 $1.89 $2.02
Weighted Average Diluted Shares Outstanding
148.80M 138.18M 123.83M 120.28M 114.68M 114.21M 110.29M 109.34M 106.93M 103.82M 98.81M
Weighted Average Basic & Diluted Shares Outstanding
147.60M 137.90M 123.50M 116.33M 112.82M 113.05M 107.04M 106.28M 101.88M 97.50M 90.73M

Quarterly Income Statements for Sally Beauty

This table shows Sally Beauty's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders
29 38 48 61 39 46 50 46 43 54 58
Consolidated Net Income / (Loss)
29 38 48 61 39 46 50 46 43 54 58
Net Income / (Loss) Continuing Operations
29 38 48 61 39 46 50 46 43 54 58
Total Pre-Tax Income
39 51 64 83 53 62 65 61 58 73 78
Total Operating Income
60 72 82 100 69 78 80 76 72 86 92
Total Gross Profit
463 481 479 477 459 481 494 483 476 490 494
Total Revenue
908 942 935 938 883 933 947 943 903 935 953
Operating Revenue
908 942 935 938 883 933 947 943 903 935 953
Total Cost of Revenue
445 461 456 461 424 452 453 460 428 445 458
Operating Cost of Revenue
445 461 456 461 424 452 453 460 428 445 458
Total Operating Expenses
403 409 397 377 389 403 414 407 404 404 402
Selling, General & Admin Expense
403 409 397 377 389 403 414 407 404 404 402
Total Other Income / (Expense), net
-21 -21 -18 -17 -16 -16 -15 -15 -14 -14 -14
Income Tax Expense
9.81 13 16 22 14 17 15 16 15 19 21
Basic Earnings per Share
$0.28 $0.37 $0.47 $0.60 $0.39 $0.46 $0.50 $0.47 $0.44 $0.57 $0.61
Weighted Average Basic Shares Outstanding
104.28M 103.19M 103.94M 102.02M 101.61M 100.46M 100.66M 97.80M 96.73M 95.06M 95.62M
Diluted Earnings per Share
$0.27 $0.36 $0.45 $0.58 $0.38 $0.44 $0.49 $0.45 $0.43 $0.55 $0.59
Weighted Average Diluted Shares Outstanding
107.08M 105.90M 106.93M 104.97M 104.44M 103.24M 103.82M 100.77M 99.72M 97.91M 98.81M
Weighted Average Basic & Diluted Shares Outstanding
103.51M 102.64M 101.88M 101.95M 100.89M 98.94M 97.50M 97.01M 95.41M 93.62M 90.73M

Annual Cash Flow Statements for Sally Beauty

This table details how cash moves in and out of Sally Beauty's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 9/30/2016 9/30/2017 9/30/2018 9/30/2019 9/30/2020 9/30/2021 9/30/2022 9/30/2023 9/30/2024 9/30/2025 9/30/2026
Net Change in Cash & Equivalents
-53 -23 14 -5.80 443 -113 -330 52 -15 41 9.00
Net Cash From Operating Activities
354 343 373 320 427 382 157 249 247 275 323
Net Cash From Continuing Operating Activities
354 343 373 320 427 382 157 249 247 275 323
Net Income / (Loss) Continuing Operations
223 215 258 272 113 240 184 185 153 196 200
Consolidated Net Income / (Loss)
223 215 258 272 113 240 184 185 153 196 200
Depreciation Expense
100 112 109 108 107 102 100 102 110 100 101
Amortization Expense
3.26 3.26 3.83 3.79 4.12 4.21 3.35 2.69 2.44 2.11 1.90
Non-Cash Adjustments To Reconcile Net Income
46 47 12 2.59 12 16 51 22 22 -2.19 25
Changes in Operating Assets and Liabilities, net
-18 -34 -9.62 -65 191 19 -182 -62 -41 -21 -4.82
Net Cash From Investing Activities
-175 -90 -95 -96 -124 -76 -102 -100 -109 -58 -112
Net Cash From Continuing Investing Activities
-175 -90 -95 -96 -124 -76 -102 -100 -109 -58 -112
Purchase of Property, Plant & Equipment
-151 -90 -87 -108 -111 -74 -99 -91 -101 -102 -112
Acquisitions
-26 - -9.18 -3.42 -13 -2.35 -3.17 -9.03 -7.75 -2.84 0.00
Sale of Property, Plant & Equipment
2.53 0.04 0.37 15 0.05 0.24 0.00 0.00 0.00 44 0.00
Divestitures
- - - - - - - 0.00 0.00 3.13 0.00
Net Cash From Financing Activities
-232 -277 -263 -229 140 -420 -374 -101 -154 -178 -200
Net Cash From Continuing Financing Activities
-232 -277 -263 -229 140 -420 -374 -101 -154 -178 -200
Repayment of Debt
-951 -1,225 -560 -778 -889 -424 -770 -1,376 -1,635 -623 -80
Repurchase of Common Equity
-209 -347 -167 -47 -61 0.00 -130 -15 -60 -54 -114
Issuance of Debt
912 1,277 462 594 1,088 0.02 520 1,290 1,541 502 0.00
Other Financing Activities, net
16 17 1.35 2.16 2.79 3.57 -1.18 -1.17 -0.00 -3.78 -6.50
Effect of Exchange Rate Changes
-0.56 - - -1.04 - 0.94 -11 3.73 - 3.08 -0.76
Cash Interest Paid
139 142 90 95 83 89 82 72 87 64 56

Quarterly Cash Flow Statements for Sally Beauty

This table details how cash moves in and out of Sally Beauty's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
-24 0.20 11 -2.43 -13 21 36 8.02 0.22 16 -15
Net Cash From Operating Activities
37 48 111 33 51 69 121 93 73 81 75
Net Cash From Continuing Operating Activities
37 48 111 33 51 69 122 93 73 81 75
Net Income / (Loss) Continuing Operations
29 38 48 61 39 46 50 46 43 54 58
Consolidated Net Income / (Loss)
29 38 48 61 39 46 50 46 43 54 58
Depreciation Expense
27 29 26 26 25 25 24 24 25 26 26
Amortization Expense
0.64 0.60 0.57 0.56 0.53 0.52 0.51 0.48 0.49 0.47 0.47
Non-Cash Adjustments To Reconcile Net Income
6.00 6.50 3.78 -20 6.33 5.37 7.02 7.73 9.52 6.74 0.56
Changes in Operating Assets and Liabilities, net
-26 -25 32 -34 -20 -6.85 40 16 -4.70 -6.57 -9.39
Net Cash From Investing Activities
-14 -19 -45 23 -19 -17 -45 -36 -29 -19 -28
Net Cash From Continuing Investing Activities
-14 -19 -45 23 -19 -17 -45 -36 -29 -19 -28
Purchase of Property, Plant & Equipment
-14 -19 -37 -20 -19 -20 -43 -36 -29 -19 -28
Net Cash From Financing Activities
-46 -29 -56 -58 -46 -34 -41 -48 -46 -45 -62
Net Cash From Continuing Financing Activities
-46 -29 -56 -58 -46 -34 -41 -48 -46 -45 -62
Repayment of Debt
-1,016 -308 -242 -155 -275 -136 -57 -20 -20 -20 -20
Repurchase of Common Equity
-20 -10 -9.89 -9.95 -10 -13 -21 -21 -26 -26 -42
Other Financing Activities, net
-0.02 0.00 -0.01 -5.26 -0.01 - -0.01 -7.34 -0.01 0.70 0.15
Effect of Exchange Rate Changes
-0.50 0.36 0.70 -1.35 - 2.57 1.39 -1.55 1.63 -0.76 -0.08
Cash Interest Paid
21 8.25 30 7.65 26 5.43 25 4.44 24 3.57 24

Annual Balance Sheets for Sally Beauty

This table presents Sally Beauty's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 9/30/2016 9/30/2017 9/30/2018 9/30/2019 9/30/2020 9/30/2021 9/30/2022 9/30/2023 9/30/2024 9/30/2025 9/30/2026
Total Assets
2,132 2,099 2,097 2,098 2,895 2,847 2,577 2,725 2,793 2,871 2,903
Total Current Assets
1,173 1,142 1,155 1,164 1,433 1,384 1,132 1,228 1,305 1,301 1,304
Cash & Equivalents
87 64 77 71 514 401 71 123 108 149 158
Accounts Receivable
84 92 90 105 56 67 72 76 92 117 90
Inventories, net
907 931 944 953 815 871 936 975 1,037 988 1,001
Other Current Assets
55 55 43 35 48 45 53 54 69 48 54
Plant, Property, & Equipment, net
320 314 308 320 315 307 298 298 270 284 285
Total Noncurrent Assets
640 643 634 615 1,147 1,156 1,147 1,199 1,218 1,285 1,314
Goodwill
533 538 536 531 540 541 526 533 538 541 538
Intangible Assets
93 80 73 62 58 56 50 55 60 53 50
Other Noncurrent Operating Assets
14 25 25 22 549 559 570 611 619 692 726
Total Liabilities & Shareholders' Equity
2,132 2,099 2,097 2,098 2,895 2,847 2,577 2,725 2,793 2,871 2,903
Total Liabilities
2,408 2,463 2,366 2,159 2,880 2,566 2,283 2,217 2,164 2,077 2,014
Total Current Liabilities
489 573 491 456 563 665 668 579 593 576 550
Short-Term Debt
0.72 96 5.50 0.00 0.18 0.19 69 4.17 4.13 4.00 4.00
Accounts Payable
271 308 303 279 236 292 276 259 269 225 206
Accrued Expenses
215 167 180 169 171 206 161 163 163 185 178
Current Deferred & Payable Income Tax Liabilities
1.99 2.23 2.14 8.34 2.92 11 4.74 2.36 20 4.26 2.07
Other Current Liabilities
- - - 0.00 153 156 158 150 136 159 160
Total Noncurrent Liabilities
1,920 1,890 1,875 1,703 2,316 1,902 1,615 1,637 1,572 1,501 1,464
Long-Term Debt
1,783 1,772 1,769 1,595 1,797 1,383 1,083 1,066 978 862 784
Capital Lease Obligations
- - - - - 404 425 455 480 538 567
Noncurrent Deferred & Payable Income Tax Liabilities
115 98 76 80 92 86 85 93 92 79 92
Other Noncurrent Operating Liabilities
22 20 30 28 427 29 22 23 22 21 21
Total Equity & Noncontrolling Interests
-276 -364 -269 -60 15 281 294 509 629 794 889
Total Preferred & Common Equity
-276 -364 -269 -60 15 281 294 509 629 794 889
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
-276 -364 -269 -60 15 281 294 509 629 794 889
Common Stock
1.45 1.30 1.20 1.17 3.04 18 5.31 6.74 1.02 0.98 0.92
Retained Earnings
-178 -283 -180 56 117 357 440 625 741 898 1,001
Accumulated Other Comprehensive Income / (Loss)
-100 -82 -90 -117 -105 -95 -152 -123 -113 -105 -113

Quarterly Balance Sheets for Sally Beauty

This table presents Sally Beauty's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 12/31/2022 3/31/2023 6/30/2023 3/31/2024 6/30/2024 12/31/2024 3/31/2025 6/30/2025 12/31/2025 3/31/2026 6/30/2026
Total Assets
2,669 2,675 2,675 2,747 2,721 2,711 2,706 2,744 2,851 2,853 2,883
Total Current Assets
1,219 1,209 1,199 1,280 1,263 1,247 1,239 1,262 1,286 1,293 1,311
Cash & Equivalents
99 62 74 97 97 106 92 113 157 157 173
Accounts Receivable
75 76 78 88 91 85 95 96 104 102 96
Inventories, net
987 1,024 996 1,040 1,022 1,006 1,007 1,005 979 987 996
Other Current Assets
58 48 51 56 51 51 45 48 45 47 46
Plant, Property, & Equipment, net
289 283 281 273 268 262 256 256 280 285 279
Total Noncurrent Assets
1,161 1,183 1,195 1,193 1,191 1,202 1,211 1,226 1,285 1,275 1,293
Goodwill
533 534 535 534 534 531 534 541 542 539 538
Intangible Assets
51 51 50 54 53 58 56 56 52 51 51
Other Noncurrent Operating Assets
577 598 610 604 604 613 621 629 691 685 704
Total Liabilities & Shareholders' Equity
2,669 2,675 2,675 2,747 2,721 2,711 2,706 2,744 2,851 2,853 2,883
Total Liabilities
2,295 2,249 2,188 2,196 2,144 2,054 2,006 1,981 2,027 2,015 2,012
Total Current Liabilities
677 631 566 644 595 549 533 524 542 553 554
Short-Term Debt
65 38 20 66 49 4.08 4.04 4.00 4.00 4.00 4.00
Accounts Payable
296 265 244 290 235 221 217 193 208 223 224
Accrued Expenses
143 168 140 150 161 149 151 165 159 170 164
Current Deferred & Payable Income Tax Liabilities
17 4.95 6.35 0.37 13 22 6.65 5.92 14 0.00 0.29
Other Current Liabilities
156 154 155 138 137 152 154 156 157 157 162
Total Noncurrent Liabilities
1,618 1,619 1,622 1,552 1,549 1,506 1,473 1,457 1,485 1,462 1,458
Long-Term Debt
1,082 1,065 1,065 978 979 938 903 882 843 823 804
Capital Lease Obligations
427 445 451 458 457 457 461 469 538 532 546
Noncurrent Deferred & Payable Income Tax Liabilities
86 86 84 94 91 89 88 85 83 86 87
Other Noncurrent Operating Liabilities
23 22 22 22 21 22 21 21 22 21 21
Total Equity & Noncontrolling Interests
373 426 488 551 578 656 700 763 824 838 871
Total Preferred & Common Equity
373 426 488 551 578 656 700 763 824 838 871
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
373 426 488 551 578 656 700 763 824 838 871
Common Stock
9.40 15 18 1.04 1.03 1.02 1.01 0.99 0.98 0.96 0.94
Retained Earnings
491 531 582 667 698 793 826 863 923 946 980
Accumulated Other Comprehensive Income / (Loss)
-127 -120 -113 -117 -122 -137 -127 -101 -101 -110 -109

Annual Metrics And Ratios for Sally Beauty

This table displays calculated financial ratios and metrics derived from Sally Beauty's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 9/30/2016 9/30/2017 9/30/2018 9/30/2019 9/30/2020 9/30/2021 9/30/2022 9/30/2023 9/30/2024 9/30/2025 9/30/2026
DEI Shares Outstanding
- - - - - - - - - - 93,622,292.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 93,622,292.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 2.14
Growth Metrics
- - - - - - - - - - -
Revenue Growth
3.08% -0.36% -0.15% -1.43% -9.34% 10.26% -1.53% -2.29% -0.30% -0.42% 0.90%
EBITDA Growth
2.16% -1.17% -9.25% 5.69% -35.14% 41.98% -15.99% -2.45% -8.19% 8.85% -0.15%
EBIT Growth
0.60% -3.95% -10.87% 7.47% -43.56% 61.71% -19.31% -3.74% -13.01% 15.94% -0.41%
NOPAT Growth
1.98% -5.10% 12.57% 2.59% -46.73% 68.62% -17.80% -6.24% -11.69% 15.95% -0.80%
Net Income Growth
-5.17% -3.53% 19.98% 5.26% -58.31% 111.80% -23.47% 0.57% -16.89% 27.68% 2.14%
EPS Growth
0.67% 4.00% 33.33% 8.65% -56.19% 112.12% -20.95% 1.81% -15.38% 32.17% 6.88%
Operating Cash Flow Growth
17.73% -3.06% 8.56% -14.02% 33.23% -10.55% -59.02% 59.30% -1.12% 11.48% 17.37%
Free Cash Flow Firm Growth
-16.54% 14.92% 24.73% -10.85% 12.26% -117.09% 303.71% 4.78% 9.20% 27.76% 16.07%
Invested Capital Growth
5.30% 1.36% -0.84% 2.40% -11.24% 28.37% 7.97% 6.18% 3.76% 3.37% 1.78%
Revenue Q/Q Growth
0.31% -0.05% -0.21% 0.00% -0.23% 0.84% -0.72% -1.09% 0.00% 0.33% 0.15%
EBITDA Q/Q Growth
-1.10% 0.38% -1.73% 2.28% 0.70% -1.97% -13.67% 9.64% 0.00% -0.98% 3.27%
EBIT Q/Q Growth
-1.66% 0.20% -1.98% 2.91% 1.40% -1.99% -17.58% 13.13% 0.00% -0.70% 3.90%
NOPAT Q/Q Growth
-1.60% -0.46% -0.20% 3.90% 4.08% -2.70% -15.70% 9.87% 0.00% 0.03% 2.79%
Net Income Q/Q Growth
-1.57% -7.29% 8.16% 5.36% 1.05% -0.84% -20.32% 13.00% 0.00% 0.97% 4.06%
EPS Q/Q Growth
-0.66% -4.29% 9.47% 6.10% 4.21% -1.41% -19.02% 12.67% 0.00% 2.16% 5.21%
Operating Cash Flow Q/Q Growth
3.33% 4.61% -7.38% 8.78% 9.19% 3.14% -26.65% 3.86% -2.32% 3.86% -12.43%
Free Cash Flow Firm Q/Q Growth
-16.36% 12.05% -3.79% 9.07% 6.93% -118.83% 152.55% -5.57% 0.00% -13.16% 8.79%
Invested Capital Q/Q Growth
0.82% -1.36% -0.47% -1.32% -2.62% 24.82% -3.60% -1.97% 0.00% 2.19% 1.65%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
49.69% 49.89% 49.44% 49.29% 48.82% 50.41% 50.30% 50.92% 50.86% 51.62% 52.05%
EBITDA Margin
15.21% 15.09% 13.71% 14.70% 10.52% 13.54% 11.56% 11.54% 10.62% 11.61% 11.49%
Operating Margin
12.61% 12.15% 10.85% 11.83% 7.36% 10.80% 8.85% 8.72% 7.61% 8.86% 8.74%
EBIT Margin
12.61% 12.15% 10.85% 11.83% 7.36% 10.80% 8.85% 8.72% 7.61% 8.86% 8.74%
Profit (Net Income) Margin
5.64% 5.46% 6.56% 7.01% 3.22% 6.19% 4.81% 4.95% 4.13% 5.29% 5.36%
Tax Burden Percent
62.97% 62.22% 78.57% 75.00% 70.79% 73.82% 75.20% 73.24% 74.36% 74.36% 74.08%
Interest Burden Percent
71.05% 72.23% 76.99% 78.99% 61.82% 77.65% 72.30% 77.55% 72.98% 80.36% 82.74%
Effective Tax Rate
37.03% 37.79% 21.43% 25.00% 29.21% 26.18% 24.80% 26.76% 25.64% 25.64% 25.92%
Return on Invested Capital (ROIC)
22.65% 20.81% 23.37% 23.79% 13.27% 20.84% 14.65% 12.83% 10.80% 12.09% 11.70%
ROIC Less NNEP Spread (ROIC-NNEP)
17.22% 16.09% 18.96% 19.30% 8.28% 15.66% 9.78% 9.16% 6.68% 8.42% 8.29%
Return on Net Nonoperating Assets (RNNOA)
-100.33% -88.04% -105.00% -188.97% -517.93% 141.13% 49.26% 33.18% 16.18% 15.44% 12.08%
Return on Equity (ROE)
-77.68% -67.23% -81.64% -165.18% -504.66% 161.97% 63.91% 46.01% 26.98% 27.54% 23.77%
Cash Return on Invested Capital (CROIC)
17.49% 19.46% 24.21% 21.42% 25.17% -4.01% 6.98% 6.83% 7.11% 8.77% 9.93%
Operating Return on Assets (OROA)
23.58% 22.62% 20.33% 21.85% 10.36% 14.57% 12.45% 12.26% 10.25% 11.58% 11.31%
Return on Assets (ROA)
10.55% 10.17% 12.30% 12.95% 4.54% 8.35% 6.77% 6.96% 5.56% 6.92% 6.93%
Return on Common Equity (ROCE)
-77.68% -67.23% -81.64% -165.18% -504.66% 161.97% 63.91% 46.01% 26.98% 27.54% 23.77%
Return on Equity Simple (ROE_SIMPLE)
-80.73% -59.15% -96.09% -450.28% 733.31% 85.44% 62.51% 36.29% 24.41% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
314 298 335 344 183 309 254 238 210 244 242
NOPAT Margin
7.94% 7.56% 8.52% 8.87% 5.21% 7.97% 6.65% 6.39% 5.66% 6.59% 6.48%
Net Nonoperating Expense Percent (NNEP)
5.43% 4.72% 4.41% 4.49% 4.99% 5.17% 4.86% 3.68% 4.12% 3.67% 3.40%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - - 11.09% 10.78%
Cost of Revenue to Revenue
50.31% 50.11% 50.56% 50.71% 51.18% 49.59% 49.70% 49.08% 49.14% 48.38% 47.95%
SG&A Expenses to Revenue
37.08% 37.16% 37.74% 37.48% 41.06% 39.49% 40.73% 41.74% 43.25% 42.77% 43.31%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
37.08% 37.74% 38.60% 37.46% 41.45% 39.61% 41.45% 42.20% 43.25% 42.77% 43.31%
Earnings before Interest and Taxes (EBIT)
498 479 427 458 259 418 338 325 283 328 326
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
601 594 539 570 370 525 441 430 395 430 429
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 0.00 63.50 6.78 4.59 1.78 2.22 2.03 1.73
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 45.96 8.03 5.11
Price to Revenue (P/Rev)
0.95 0.65 0.56 0.46 0.28 0.49 0.35 0.24 0.37 0.44 0.41
Price to Earnings (P/E)
16.87 11.96 8.56 6.61 8.66 7.94 7.35 4.89 9.08 8.22 7.68
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
5.93% 8.36% 11.68% 15.13% 11.55% 12.59% 13.61% 20.44% 11.01% 12.16% 13.02%
Enterprise Value to Invested Capital (EV/IC)
3.84 3.04 2.73 2.27 1.74 1.97 1.59 1.21 1.39 1.40 1.31
Enterprise Value to Revenue (EV/Rev)
1.38 1.11 0.99 0.86 0.64 0.85 0.75 0.62 0.74 0.77 0.73
Enterprise Value to EBITDA (EV/EBITDA)
9.08 7.37 7.24 5.82 6.12 6.27 6.47 5.36 6.96 6.67 6.37
Enterprise Value to EBIT (EV/EBIT)
10.95 9.14 9.16 7.24 8.75 7.86 8.45 7.09 9.72 8.74 8.38
Enterprise Value to NOPAT (EV/NOPAT)
17.40 14.70 11.65 9.65 12.36 10.65 11.24 9.68 13.07 11.76 11.31
Enterprise Value to Operating Cash Flow (EV/OCF)
15.41 12.75 10.48 10.36 5.30 8.62 18.24 9.25 11.14 10.43 8.48
Enterprise Value to Free Cash Flow (EV/FCFF)
22.53 15.72 11.25 10.72 6.51 0.00 23.59 18.18 19.84 16.20 13.32
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
-6.46 -5.14 -6.61 -26.43 116.37 6.36 5.37 3.00 2.33 1.77 1.52
Long-Term Debt to Equity
-6.46 -4.87 -6.59 -26.43 116.36 6.36 5.13 2.99 2.32 1.76 1.52
Financial Leverage
-5.83 -5.47 -5.54 -9.79 -62.52 9.01 5.03 3.62 2.42 1.83 1.46
Leverage Ratio
-7.36 -6.61 -6.64 -12.76 -111.27 19.39 9.44 6.61 4.85 3.98 3.43
Compound Leverage Factor
-5.23 -4.78 -5.11 -10.08 -68.79 15.06 6.83 5.12 3.54 3.20 2.84
Debt to Total Capital
118.32% 124.17% 117.84% 103.93% 99.15% 86.42% 84.30% 74.99% 69.93% 63.88% 60.38%
Short-Term Debt to Total Capital
0.05% 6.39% 0.37% 0.00% 0.01% 0.01% 3.67% 0.21% 0.20% 0.18% 0.18%
Long-Term Debt to Total Capital
118.27% 117.78% 117.47% 103.93% 99.14% 86.41% 80.63% 74.78% 69.74% 63.69% 60.21%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
-18.32% -24.17% -17.84% -3.93% 0.85% 13.58% 15.70% 25.01% 30.07% 36.12% 39.62%
Debt to EBITDA
2.97 3.14 3.29 2.80 4.86 3.40 3.58 3.55 3.70 3.27 3.16
Net Debt to EBITDA
2.82 3.04 3.15 2.67 3.47 2.64 3.42 3.26 3.43 2.92 2.79
Long-Term Debt to EBITDA
2.97 2.98 3.28 2.80 4.86 3.40 3.42 3.54 3.69 3.26 3.15
Debt to NOPAT
5.69 6.27 5.29 4.64 9.81 5.78 6.21 6.41 6.95 5.76 5.60
Net Debt to NOPAT
5.41 6.06 5.06 4.43 7.00 4.49 5.93 5.89 6.44 5.15 4.95
Long-Term Debt to NOPAT
5.68 5.95 5.28 4.64 9.81 5.78 5.94 6.39 6.93 5.75 5.59
Altman Z-Score
3.83 3.39 3.37 3.51 2.13 2.77 2.72 2.61 2.73 2.87 2.91
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.40 1.99 2.35 2.55 2.54 2.08 1.70 2.12 2.20 2.26 2.37
Quick Ratio
0.35 0.27 0.34 0.39 1.01 0.70 0.21 0.34 0.34 0.46 0.45
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
242 278 347 310 348 -59 121 127 138 177 205
Operating Cash Flow to CapEx
238.16% 383.02% 432.63% 346.61% 385.26% 518.35% 157.68% 274.75% 243.69% 469.23% 286.86%
Free Cash Flow to Firm to Interest Expense
1.68 2.10 3.54 3.21 3.52 -0.64 1.29 1.74 1.81 2.75 0.00
Operating Cash Flow to Interest Expense
2.46 2.58 3.80 3.33 4.32 4.08 1.67 3.42 3.23 4.27 0.00
Operating Cash Flow Less CapEx to Interest Expense
1.42 1.91 2.92 2.37 3.20 3.30 0.61 2.17 1.90 3.36 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.87 1.86 1.87 1.85 1.41 1.35 1.41 1.41 1.35 1.31 1.29
Accounts Receivable Turnover
45.15 44.70 43.04 39.75 43.67 63.00 54.96 50.33 44.23 35.46 36.13
Inventory Turnover
2.22 2.15 2.12 2.07 2.04 2.28 2.10 1.91 1.82 1.77 1.80
Fixed Asset Turnover
13.39 12.44 12.64 12.35 11.07 12.45 12.61 12.52 13.10 13.36 13.12
Accounts Payable Turnover
7.27 6.82 6.51 6.76 6.99 7.28 6.69 6.85 6.92 7.25 8.32
Days Sales Outstanding (DSO)
8.08 8.17 8.48 9.18 8.36 5.79 6.64 7.25 8.25 10.29 10.10
Days Inventory Outstanding (DIO)
164.50 169.99 172.13 176.13 179.32 160.11 173.97 190.64 201.00 206.30 202.67
Days Payable Outstanding (DPO)
50.22 53.56 56.09 54.02 52.25 50.14 54.60 53.32 52.78 50.34 43.89
Cash Conversion Cycle (CCC)
122.36 124.60 124.53 131.29 135.43 115.76 126.01 144.58 156.47 166.25 168.89
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,421 1,441 1,428 1,463 1,298 1,667 1,800 1,911 1,983 2,049 2,086
Invested Capital Turnover
2.85 2.75 2.74 2.68 2.55 2.61 2.20 2.01 1.91 1.84 1.81
Increase / (Decrease) in Invested Capital
71 19 -12 34 -164 368 133 111 72 67 37
Enterprise Value (EV)
5,458 4,376 3,906 3,318 2,264 3,291 2,854 2,305 2,747 2,866 2,734
Market Capitalization
3,761 2,572 2,209 1,795 981 1,905 1,348 903 1,393 1,611 1,537
Book Value per Share
($1.89) ($2.77) ($2.24) ($0.50) $0.14 $2.48 $2.74 $4.72 $6.12 $8.03 $9.50
Tangible Book Value per Share
($6.16) ($7.47) ($7.30) ($5.42) ($5.17) ($2.80) ($2.64) ($0.74) $0.30 $2.03 $3.21
Total Capital
1,508 1,504 1,506 1,534 1,813 2,068 1,870 2,034 2,091 2,199 2,244
Total Debt
1,784 1,868 1,774 1,595 1,797 1,787 1,576 1,525 1,462 1,404 1,355
Total Long-Term Debt
1,783 1,772 1,769 1,595 1,797 1,787 1,508 1,521 1,458 1,400 1,351
Net Debt
1,697 1,804 1,697 1,523 1,283 1,386 1,506 1,402 1,354 1,255 1,197
Capital Expenditures (CapEx)
149 90 86 92 111 74 99 91 101 59 112
Debt-free, Cash-free Net Working Capital (DFCFNWC)
598 602 592 636 356 318 463 530 609 580 599
Debt-free Net Working Capital (DFNWC)
685 666 669 707 870 719 533 653 717 729 758
Net Working Capital (NWC)
684 569 664 707 870 719 464 649 713 725 754
Net Nonoperating Expense (NNE)
91 83 77 72 70 69 70 53 57 48 42
Net Nonoperating Obligations (NNO)
1,697 1,804 1,697 1,523 1,283 1,386 1,506 1,402 1,354 1,255 1,197
Total Depreciation and Amortization (D&A)
103 116 113 111 111 106 103 105 112 102 103
Debt-free, Cash-free Net Working Capital to Revenue
15.14% 15.28% 15.06% 16.41% 10.12% 8.20% 12.12% 14.21% 16.38% 15.68% 16.05%
Debt-free Net Working Capital to Revenue
17.33% 16.90% 17.02% 18.25% 24.75% 18.55% 13.97% 17.51% 19.28% 19.71% 20.29%
Net Working Capital to Revenue
17.31% 14.46% 16.88% 18.25% 24.75% 18.55% 12.17% 17.40% 19.17% 19.60% 20.18%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.51 $1.56 $2.09 $2.27 $0.99 $2.13 $1.69 $1.72 $1.48 $1.95 $2.09
Adjusted Weighted Average Basic Shares Outstanding
147.18M 137.53M 123.19M 119.64M 113.88M 112.65M 108.67M 107.33M 103.94M 100.66M 95.62M
Adjusted Diluted Earnings per Share
$1.50 $1.56 $2.08 $2.26 $0.99 $2.10 $1.66 $1.69 $1.43 $1.89 $2.02
Adjusted Weighted Average Diluted Shares Outstanding
148.80M 138.18M 123.83M 120.28M 114.68M 114.21M 110.29M 109.34M 106.93M 103.82M 98.81M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
144.11M 128.43M 120.14M 116.33M 112.82M 113.05M 107.04M 106.28M 101.88M 97.50M 90.73M
Normalized Net Operating Profit after Tax (NOPAT)
314 312 362 343 193 312 275 251 210 244 242
Normalized NOPAT Margin
7.94% 7.92% 9.19% 8.86% 5.50% 8.06% 7.20% 6.72% 5.65% 6.59% 6.48%
Pre Tax Income Margin
8.96% 8.78% 8.35% 9.34% 4.55% 8.39% 6.40% 6.76% 5.55% 7.12% 7.23%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
3.45 3.60 4.35 4.76 2.62 4.47 3.61 4.45 3.70 5.09 0.00
NOPAT to Interest Expense
2.18 2.24 3.41 3.57 1.85 3.30 2.71 3.26 2.75 3.79 0.00
EBIT Less CapEx to Interest Expense
2.42 2.93 3.47 3.80 1.50 3.69 2.55 3.21 2.38 4.18 0.00
NOPAT Less CapEx to Interest Expense
1.14 1.57 2.54 2.61 0.73 2.52 1.65 2.02 1.43 2.88 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
93.78% 161.28% 64.60% 17.46% 54.18% 0.00% 71.00% 8.21% 39.37% 27.57% 56.91%

Quarterly Metrics And Ratios for Sally Beauty

This table displays calculated financial ratios and metrics derived from Sally Beauty's official financial filings.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
- - - - - - - - 97,008,814.00 95,408,486.00 93,622,292.00
DEI Adjusted Shares Outstanding
- - - - - - - - 97,008,814.00 95,408,486.00 93,622,292.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - 0.44 0.57 0.62
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-1.13% 1.22% 1.48% 0.71% -2.78% -0.96% 1.29% 0.56% 2.29% 0.23% 0.58%
EBITDA Growth
-38.67% -13.21% 4.61% 29.26% 9.29% 2.45% -3.91% -20.88% 2.56% 9.42% 12.98%
EBIT Growth
-16.57% -20.37% 6.97% 45.13% 16.45% 8.92% -2.82% -24.31% 3.69% 10.52% 15.32%
NOPAT Growth
-16.33% -17.26% 7.20% 44.19% 14.86% 7.92% 0.05% -23.61% 3.75% 12.31% 10.67%
Net Income Growth
-28.43% -25.77% 12.86% 58.93% 34.08% 21.21% 3.90% -25.33% 8.89% 18.28% 15.65%
EPS Growth
-27.03% -21.74% 12.50% 65.71% 40.74% 22.22% 8.89% -22.41% 13.16% 25.00% 20.41%
Operating Cash Flow Growth
0.00% -9.84% -5.03% -34.42% 38.24% 44.97% 9.22% 178.68% 43.51% 16.58% -37.88%
Free Cash Flow Firm Growth
104.06% 300.12% 80.77% -198.74% 2,819.18% -52.99% 47.48% 97.64% -133.23% 2.87% 676.78%
Invested Capital Growth
2.28% 0.84% 3.76% 0.00% 1.00% 2.04% 3.37% 5.17% 3.22% 2.32% 1.78%
Revenue Q/Q Growth
0.00% 3.74% -0.78% 0.00% -5.84% 5.68% 1.48% -0.41% -4.22% 3.55% 1.82%
EBITDA Q/Q Growth
0.00% 69.35% 8.08% 0.00% -24.67% 8.50% 1.37% -4.52% -2.34% 15.75% 4.68%
EBIT Q/Q Growth
0.00% 20.47% 14.62% 0.00% -30.85% 12.69% 2.27% -5.01% -5.27% 20.11% 6.71%
NOPAT Q/Q Growth
0.00% 18.85% 15.77% 0.00% -30.62% 11.67% 7.33% -8.14% -5.77% 20.89% 5.77%
Net Income Q/Q Growth
0.00% 29.00% 27.39% 0.00% -35.74% 16.61% 9.20% -8.76% -6.28% 26.67% 6.77%
EPS Q/Q Growth
0.00% 33.33% 25.00% 0.00% -34.48% 15.79% 11.36% -8.16% -4.44% 27.91% 7.27%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 131.07% -69.77% 52.63% 35.97% 74.10% -22.87% -21.41% 10.46% -7.22%
Free Cash Flow Firm Q/Q Growth
0.00% 3,280.53% -128.34% 0.00% 101.69% -45.57% -131.66% -712.13% 76.26% 268.48% 77.54%
Invested Capital Q/Q Growth
0.00% 0.47% 0.87% 0.00% 1.34% 1.50% 2.19% 0.05% -0.54% 0.61% 1.65%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
50.98% 51.03% 51.25% 50.84% 51.95% 51.54% 52.17% 51.24% 52.67% 52.41% 51.91%
EBITDA Margin
6.56% 10.71% 11.66% 13.48% 10.79% 11.07% 11.06% 10.61% 10.81% 12.09% 12.43%
Operating Margin
6.56% 7.62% 8.80% 10.70% 7.86% 8.38% 8.44% 8.05% 7.96% 9.24% 9.68%
EBIT Margin
6.56% 7.62% 8.80% 10.70% 7.86% 8.38% 8.44% 8.05% 7.96% 9.24% 9.68%
Profit (Net Income) Margin
3.22% 4.00% 5.14% 6.51% 4.44% 4.90% 5.27% 4.83% 4.73% 5.78% 6.06%
Tax Burden Percent
74.89% 73.88% 74.62% 73.62% 73.86% 73.20% 76.83% 74.30% 73.91% 74.39% 73.73%
Interest Burden Percent
65.55% 71.15% 78.29% 82.61% 76.52% 79.90% 81.30% 80.75% 80.31% 84.15% 84.95%
Effective Tax Rate
25.11% 26.12% 25.38% 26.38% 26.14% 26.80% 23.17% 25.70% 26.09% 25.61% 26.27%
Return on Invested Capital (ROIC)
0.00% 0.00% 12.54% 30.08% 10.91% 11.39% 11.91% 11.09% 10.92% 12.63% 12.89%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 11.57% 28.09% 10.02% 10.52% 11.03% 10.22% 10.08% 11.79% 12.05%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 28.03% 55.34% 21.48% 20.64% 20.22% 17.41% 16.24% 17.48% 17.56%
Return on Equity (ROE)
0.00% 0.00% 40.57% 85.42% 32.39% 32.03% 32.13% 28.49% 27.17% 30.10% 30.45%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 7.11% -176.12% 11.18% 10.26% 8.77% 6.28% 8.20% 9.30% 9.93%
Operating Return on Assets (OROA)
0.00% 0.00% 11.85% 14.69% 10.66% 11.31% 11.03% 10.73% 10.68% 12.24% 12.52%
Return on Assets (ROA)
0.00% 0.00% 6.92% 8.94% 6.02% 6.61% 6.89% 6.44% 6.34% 7.66% 7.84%
Return on Common Equity (ROCE)
0.00% 0.00% 40.57% 85.42% 32.39% 32.03% 32.13% 28.49% 27.17% 30.10% 30.45%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% 0.00% 26.81% 26.58% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
45 53 61 74 51 57 61 56 53 64 68
NOPAT Margin
4.91% 5.63% 6.57% 7.87% 5.80% 6.13% 6.49% 5.98% 5.89% 6.87% 7.14%
Net Nonoperating Expense Percent (NNEP)
1.06% 1.07% 0.97% 1.99% 0.90% 0.87% 0.88% 0.86% 0.85% 0.84% 0.83%
Return On Investment Capital (ROIC_SIMPLE)
- - 2.94% 3.59% 2.48% 2.70% 2.79% 2.56% 2.42% 2.89% 3.03%
Cost of Revenue to Revenue
49.02% 48.97% 48.75% 49.16% 48.05% 48.46% 47.83% 48.76% 47.33% 47.59% 48.09%
SG&A Expenses to Revenue
44.41% 43.37% 42.50% 40.15% 44.10% 43.16% 43.73% 43.19% 44.70% 43.17% 42.23%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
44.42% 43.41% 42.45% 40.15% 44.10% 43.16% 43.73% 43.19% 44.70% 43.17% 42.23%
Earnings before Interest and Taxes (EBIT)
60 72 82 100 69 78 80 76 72 86 92
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
60 101 109 126 95 103 105 100 98 113 118
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 1.92 2.22 1.62 1.32 1.22 2.03 1.69 1.60 1.55 1.73
Price to Tangible Book Value (P/TBV)
0.00 0.00 45.96 15.82 8.38 5.64 8.03 6.05 5.43 4.78 5.11
Price to Revenue (P/Rev)
0.00 0.00 0.37 0.29 0.25 0.25 0.44 0.38 0.36 0.36 0.41
Price to Earnings (P/E)
0.00 0.00 9.08 6.05 4.95 4.82 8.22 7.71 7.31 7.02 7.68
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 11.01% 16.53% 20.20% 20.77% 12.16% 12.98% 13.69% 14.25% 13.02%
Enterprise Value to Invested Capital (EV/IC)
0.00 1.27 1.39 1.21 1.11 1.09 1.40 1.28 1.25 1.23 1.31
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.74 0.63 0.59 0.59 0.77 0.71 0.68 0.68 0.73
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 6.96 5.57 5.09 5.01 6.67 6.49 6.27 6.09 6.37
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 9.72 7.51 6.79 6.59 8.74 8.63 8.32 8.05 8.38
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 13.07 10.13 9.17 8.93 11.76 11.56 11.15 10.75 11.31
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 9.90 11.14 10.30 9.04 8.23 10.43 7.82 7.13 6.87 8.48
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 19.84 0.00 9.99 10.69 16.20 20.83 15.47 13.40 13.32
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
2.73 2.57 2.33 2.13 1.96 1.78 1.77 1.68 1.62 1.55 1.52
Long-Term Debt to Equity
2.61 2.49 2.32 2.12 1.95 1.77 1.76 1.68 1.62 1.55 1.52
Financial Leverage
2.96 2.67 2.42 1.97 2.14 1.96 1.83 1.70 1.61 1.48 1.46
Leverage Ratio
5.55 5.07 4.85 4.13 4.36 4.08 3.98 3.76 3.62 3.44 3.43
Compound Leverage Factor
3.64 3.60 3.80 3.41 3.34 3.26 3.24 3.03 2.90 2.90 2.91
Debt to Total Capital
73.17% 72.00% 69.93% 68.06% 66.16% 63.98% 63.88% 62.70% 61.86% 60.84% 60.38%
Short-Term Debt to Total Capital
3.22% 2.38% 0.20% 0.20% 0.20% 0.19% 0.18% 0.18% 0.18% 0.18% 0.18%
Long-Term Debt to Total Capital
69.95% 69.61% 69.74% 67.86% 65.96% 63.80% 63.69% 62.51% 61.68% 60.66% 60.21%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
26.83% 28.00% 30.07% 31.94% 33.84% 36.02% 36.12% 37.30% 38.14% 39.16% 39.62%
Debt to EBITDA
0.00 0.00 3.70 3.30 3.17 3.12 3.27 3.43 3.35 3.26 3.16
Net Debt to EBITDA
0.00 0.00 3.43 3.05 2.96 2.86 2.92 3.04 2.96 2.84 2.79
Long-Term Debt to EBITDA
0.00 0.00 3.69 3.29 3.16 3.11 3.26 3.42 3.34 3.25 3.15
Debt to NOPAT
0.00 0.00 6.95 6.01 5.71 5.56 5.76 6.11 5.95 5.75 5.60
Net Debt to NOPAT
0.00 0.00 6.44 5.56 5.33 5.10 5.15 5.42 5.26 5.02 4.95
Long-Term Debt to NOPAT
0.00 0.00 6.93 5.99 5.70 5.55 5.75 6.10 5.94 5.74 5.59
Altman Z-Score
0.00 0.00 2.49 2.53 2.47 2.48 2.59 2.57 2.56 2.59 2.64
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.99 2.12 2.20 2.27 2.32 2.41 2.26 2.37 2.34 2.37 2.37
Quick Ratio
0.29 0.32 0.34 0.35 0.35 0.40 0.46 0.48 0.47 0.49 0.45
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
1.08 37 -10 -1,876 32 17 -5.45 -44 -11 18 31
Operating Cash Flow to CapEx
0.00% 250.12% 296.26% 0.00% 270.28% 342.02% 281.94% 260.56% 251.29% 419.15% 266.44%
Free Cash Flow to Firm to Interest Expense
0.05 1.77 -0.58 -107.55 1.94 1.10 -0.36 -3.03 -0.74 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 2.31 6.20 1.92 3.13 4.42 8.08 6.38 5.17 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 1.39 4.10 3.27 1.98 3.13 5.22 3.93 3.11 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.00 0.00 1.35 1.37 1.36 1.35 1.31 1.33 1.34 1.33 1.29
Accounts Receivable Turnover
0.00 0.00 44.23 44.00 40.51 39.38 35.46 39.24 37.91 38.87 36.13
Inventory Turnover
0.00 0.00 1.82 1.81 1.76 1.77 1.77 1.80 1.80 1.78 1.80
Fixed Asset Turnover
0.00 0.00 13.10 14.23 13.98 14.07 13.36 13.68 13.77 13.92 13.12
Accounts Payable Turnover
0.00 0.00 6.92 8.26 7.11 8.39 7.25 8.34 8.15 8.57 8.32
Days Sales Outstanding (DSO)
0.00 0.00 8.25 8.30 9.01 9.27 10.29 9.30 9.63 9.39 10.10
Days Inventory Outstanding (DIO)
0.00 0.00 201.00 201.35 207.17 206.33 206.30 202.41 202.92 204.54 202.67
Days Payable Outstanding (DPO)
0.00 0.00 52.78 44.16 51.34 43.51 50.34 43.76 44.80 42.61 43.89
Cash Conversion Cycle (CCC)
0.00 0.00 156.47 165.48 164.84 172.09 166.25 167.95 167.74 171.32 168.89
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,956 1,965 1,983 1,950 1,976 2,005 2,049 2,051 2,040 2,052 2,086
Invested Capital Turnover
0.00 0.00 1.91 3.82 1.88 1.86 1.84 1.85 1.86 1.84 1.81
Increase / (Decrease) in Invested Capital
44 16 72 1,950 20 40 67 101 64 47 37
Enterprise Value (EV)
0.00 2,499 2,747 2,358 2,197 2,177 2,866 2,617 2,545 2,530 2,734
Market Capitalization
0.00 1,111 1,393 1,065 921 934 1,611 1,390 1,344 1,349 1,537
Book Value per Share
$5.28 $5.58 $6.12 $6.44 $6.86 $7.56 $8.03 $8.45 $8.64 $9.13 $9.50
Tangible Book Value per Share
($0.36) ($0.09) $0.30 $0.66 $1.08 $1.64 $2.03 $2.36 $2.55 $2.96 $3.21
Total Capital
2,053 2,063 2,091 2,055 2,068 2,118 2,199 2,208 2,197 2,225 2,244
Total Debt
1,503 1,485 1,462 1,399 1,368 1,355 1,404 1,384 1,359 1,354 1,355
Total Long-Term Debt
1,436 1,436 1,458 1,395 1,364 1,351 1,400 1,380 1,355 1,350 1,351
Net Debt
1,405 1,388 1,354 1,293 1,276 1,243 1,255 1,227 1,202 1,181 1,197
Capital Expenditures (CapEx)
0.00 19 37 -23 19 20 43 36 29 19 28
Debt-free, Cash-free Net Working Capital (DFCFNWC)
606 619 609 597 618 629 580 590 586 588 599
Debt-free Net Working Capital (DFNWC)
703 717 717 702 710 742 729 748 743 761 758
Net Working Capital (NWC)
637 668 713 698 706 738 725 744 739 757 754
Net Nonoperating Expense (NNE)
15 15 13 13 12 11 11 11 10 10 10
Net Nonoperating Obligations (NNO)
1,405 1,388 1,354 1,293 1,276 1,243 1,255 1,227 1,202 1,181 1,197
Total Depreciation and Amortization (D&A)
0.00 29 27 26 26 25 25 24 26 27 26
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 0.00% 16.38% 16.02% 16.70% 17.05% 15.68% 15.93% 15.72% 15.77% 16.05%
Debt-free Net Working Capital to Revenue
0.00% 0.00% 19.28% 18.86% 19.19% 20.11% 19.71% 20.17% 19.94% 20.42% 20.29%
Net Working Capital to Revenue
0.00% 0.00% 19.17% 18.75% 19.08% 20.00% 19.60% 20.06% 19.84% 20.31% 20.18%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.28 $0.37 $0.47 $0.60 $0.39 $0.46 $0.50 $0.47 $0.44 $0.57 $0.61
Adjusted Weighted Average Basic Shares Outstanding
104.28M 103.19M 103.94M 102.02M 101.61M 100.46M 100.66M 97.80M 96.73M 95.06M 95.62M
Adjusted Diluted Earnings per Share
$0.27 $0.36 $0.45 $0.58 $0.38 $0.44 $0.49 $0.45 $0.43 $0.55 $0.59
Adjusted Weighted Average Diluted Shares Outstanding
107.08M 105.90M 106.93M 104.97M 104.44M 103.24M 103.82M 100.77M 99.72M 97.91M 98.81M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
103.51M 102.64M 101.88M 101.95M 100.89M 98.94M 97.50M 97.01M 95.41M 93.62M 90.73M
Normalized Net Operating Profit after Tax (NOPAT)
45 53 61 74 51 57 61 56 53 64 68
Normalized NOPAT Margin
4.92% 5.66% 6.53% 7.87% 5.80% 6.13% 6.49% 5.98% 5.89% 6.87% 7.14%
Pre Tax Income Margin
4.30% 5.42% 6.89% 8.84% 6.01% 6.69% 6.86% 6.50% 6.39% 7.77% 8.22%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
2.90 3.47 4.61 5.75 4.26 4.98 5.35 5.19 5.08 0.00 0.00
NOPAT to Interest Expense
2.17 2.56 3.44 4.23 3.15 3.64 4.11 3.86 3.75 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 2.54 2.51 7.10 3.10 3.68 2.48 2.75 3.02 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 1.64 1.35 5.58 1.99 2.35 1.24 1.41 1.69 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 39.37% 28.48% 21.60% 22.28% 27.57% 35.92% 43.59% 48.16% 56.91%

Financials Breakdown Chart

Key Financial Trends

Sally Beauty’s latest results show improving profitability and cash generation, although revenue growth remains modest and gross margin has edged lower. In Q4 2026, revenue was $952.5 million, up about 0.6% from Q4 2025, while net income rose about 16% to $57.7 million. The supplied balance-sheet data runs through Q3 2026, so it does not show the company’s Q4 2026 year-end position.

  • Profitability improved year over year. Q4 operating income increased to $92.2 million from $79.9 million a year earlier, and net income rose to $57.7 million from $49.9 million. Lower selling, general and administrative expense contributed to the operating-income gain.
  • Full-year operating cash flow and estimated free cash flow increased. Across FY2026, operating cash flow totaled about $322.6 million, versus $274.8 million in FY2025. After property and equipment purchases, estimated free cash flow was about $210.1 million, up from $172.7 million.
  • Share count reduction supported per-share results. Q4 diluted weighted-average shares fell to 98.8 million from 103.8 million a year earlier, while diluted EPS rose to $0.59 from $0.49.
  • Long-term debt has trended down from earlier levels. At Q3 2026, long-term debt was $803.6 million, below the $978.9 million reported in Q3 2024. Lease obligations remain substantial, however.
  • Revenue is recovering gradually, not rapidly. Q4 revenue rose from $921.4 million in 2023 to $952.5 million in 2026, but the latest year-over-year increase was less than 1%.
  • Inventory remains a major balance-sheet item. Inventory was about $996 million at Q3 2026, slightly below the $1.01 billion a year earlier. It represents a large share of current assets, making inventory management important to liquidity and cash flow.
  • Gross margin slipped slightly in the latest annual comparison. Q4 gross margin was about 51.9%, compared with 52.2% in Q4 2025. Gross profit was nearly flat despite the modest revenue increase.
  • Quarterly cash flow and cash balances can be uneven. Q4 2026 operating cash flow was $75.1 million, down from $80.9 million in Q3, while capital spending rose to $28.2 million from $19.3 million. Cash decreased by $14.9 million during Q4.
  • Debt and lease obligations remain significant. At Q3 2026, long-term debt, short-term debt and capital lease obligations together totaled about $1.35 billion. Ongoing interest costs and required payments may limit financial flexibility.
11/16/26 09:50 AM ETAI Generated. May Contain Errors.

Sally Beauty Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Sally Beauty's financial year ends in September. Their financial year 2026 ended on September 30, 2026.

Sally Beauty's net income appears to be on a downward trend, with a most recent value of $200.08 million in 2026, falling from $222.94 million in 2016. The previous period was $195.88 million in 2025. Find out what analysts predict for Sally Beauty in the coming months.

Sally Beauty's total operating income in 2026 was $326.45 million, based on the following breakdown:
  • Total Gross Profit: $1.94 billion
  • Total Operating Expenses: $1.62 billion

Over the last 10 years, Sally Beauty's total revenue changed from $3.95 billion in 2016 to $3.73 billion in 2026, a change of -5.5%.

In the past 14 quarters, Sally Beauty's cash and equivalents has ranged from $61.62 million in Q2 2023 to $173.10 million in Q3 2026, and is currently $173.10 million as of their latest financial filing in Q3 2026.

Sally Beauty had total debt of $1.36 billion at the end of 2026, a 3.5% decrease from 2025, and a 24.0% decrease since 2016.

Over the last 10 years, Sally Beauty's book value per share changed from -1.89 in 2016 to 9.50 in 2026.



Financial statements for NYSE:SBH last updated on 11/10/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners